Biogen Accused Of Stifling Neurological Drug Competition
Biogen Inc. is facing an antitrust suit in California federal court filed Tuesday by Ixchel Pharma LLC alleging it attempted to hold a monopoly on drug treatments containing dimethyl fumarate, preventing...To view the full article, register now.
Already a subscriber? Click here to view full article